
Ono Pharmaceutical Co. Ltd.
OPHLY | OTC
$5.42
+$0.27 (+5.24%)
Sep 22, 2026, 10:56 AM ET · Market open
Fiscal Year Period Ending | FY 2026 Mar 30, 2026 | FY 2025 Mar 30, 2025 | FY 2024 Mar 30, 2024 | FY 2023 Mar 30, 2023 | FY 2022 Mar 30, 2022 | FY 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 238.07B | 204.57B | 166.14B | 96.14B | 69.11B | 61.05B |
Short-Term Investments | 60.26M | 5.81B | 38.45B | 68.15B | 47.86B | 43.93B |
Long-Term Investments | 101.74B | 88.56B | 297.17B | 324.18B | 256B | 234.87B |
Other Long-Term Assets | 3.51B | 12.42B | 40.86B | 324.18B | 1M | 46.53B |
Receivables | 146.57B | 135.02B | 136.07B | 114.4B | 99.79B | 84.27B |
Inventory | 57.7B | 74.86B | 48.63B | 44.81B | 41.82B | 39.15B |
Other Current Assets | 27.94B | 34.84B | 9.61B | 11.14B | 11.74B | 9.24B |
Total Current Assets | 470.34B | 455.1B | 413.6B | 345.1B | 281.27B | 247.64B |
Property-Plant & Equipment | 101.86B | 105.72B | 104.75B | 108.42B | 112.13B | 113.87B |
Goodwill & Intangibles | 377.87B | 351.23B | 57.29B | 69.13B | 64.73B | 70.32B |
Total Long-Term Assets | 640.98B | 608.94B | 500.07B | 537.34B | 457.94B | 499.2B |
Total Assets | 1.11T | 1.06T | 913.67B | 882.44B | 739.2B | 746.84B |
Account Payables | 63.22B | 89.33B | 60.69B | 66.79B | 49.69B | 39.16B |
Deferred Revenue | n/a | n/a | n/a | 35.24B | 2.24B | 40.38B |
Short-Term Debt | 38.63B | 30B | 15.26M | 18.71M | 18.96M | 18.31M |
Other Current Liabilities | 31.59B | 21.73B | 5.02B | -27.91B | 851.04M | -17.3B |
Total Current Liabilities | 164.35B | 148.3B | 103.62B | 122.93B | 65.93B | 93.73B |
Long-Term Debt | 75.33B | 105B | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 2.86B | 3.23B | 3.87B | 4.03B | 4.09B | 3.87B |
Total Long-Term Liabilities | 86.6B | 127.55B | 11.44B | 11.7B | 11.6B | 11.95B |
Total Liabilities | 250.96B | 275.84B | 115.06B | 134.62B | 77.53B | 105.69B |
Total Debt | 121.46B | 146.68B | 8.86B | 9.17B | 8.8B | 9.05B |
Book Value | 860.36B | 788.2B | 798.61B | 747.81B | 661.67B | 641.16B |
Book Value Per Share | 610.21 | 559.28 | 554.54 | 170.13 | 148.05 | 142.69 |
Common Stock | 17.43B | 17.36B | 17.36B | 17.36B | 17.36B | 17.36B |
Retained Earnings | 833.69B | 790.91B | 768.18B | 709.89B | 644.75B | 583.36B |
Comprehensive Income | 48.89B | 19.79B | 53.2B | 51.7B | 51.24B | 62.3B |
Shareholders Equity | 854.42B | 782.45B | 792.96B | 741.87B | 655.91B | 635.55B |
Total Investments | 101.8B | 94.37B | 335.62B | 392.33B | 256.06B | 278.8B |
Add to Watchlist
Select watchlists to add or remove OPHLY